# A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy

> **NCT01030094** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 140 (actual)

## Conditions studied

- Seizures
- Convulsions
- Epilepsy
- Osteopenia
- Osteoporosis

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Carbamazepine
- **DRUG:** Valproic acid
- **DRUG:** Normal control

## Key facts

- **NCT ID:** NCT01030094
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01030094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01030094, "A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01030094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*